Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

793 public trials 102 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

NCT05987449

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • UC Davis Cancer Center Sacramento, California, United States
  • Georgetown Uni Medical Center Washington D.C., District of Columbia, United States
  • Indiana Hemophilia & Thrombosis center Indianapolis, Indiana, United States
  • University of Iowa Hospitals and Clnics Dept of Pediatrics Iowa City, Iowa, United States
View all 14 locations
View Trial Details
Recruiting

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

NCT05582993

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • Riley Hospital for Children Indiana University Health Indianapolis, Indiana, United States
  • University of Iowa Hospitals & Clinics PARENT Iowa City, Iowa, United States
View all 23 locations
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

NCT06998524

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • UC Davis Sacramento, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Minnesota Medical Center Minneapolis, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 29 locations
View Trial Details
Recruiting

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

NCT07416604

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Center for Inherited Blood Disorders Orange, California, United States
  • Innovative Hematology, Inc. Indianapolis, Indiana, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • Washington Center for Bleeding Disorders Seattle, Washington, United States
View all 42 locations
View Trial Details
Recruiting

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

NCT06003387

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • University of California, San Diego (UCSD) San Diego, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Hemophilia Center of Western Pennsylvania (HCWP) Pittsburgh, Pennsylvania, United States
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
View all 32 locations
View Trial Details
Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT04398628

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +34 more
Locations
  • Arizona Hemophilia and Thrombosis Treatment Center at Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Center for Bleeding Disorders Little Rock, Arkansas, United States
  • Orthopaedic Institute for Children HTC Los Angeles, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
View all 76 locations
View Trial Details
Recruiting

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

NCT07285460

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • The Luskin Orthopaedic Institute for Children- Site Number : 8400013 Los Angeles, California, United States
  • The Center for Inherited Blood Disorders- Site Number : 8400009 Orange, California, United States
  • Cure 4 The Kids Foundation- Site Number : 8400001 Las Vegas, Nevada, United States
  • Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400008 Hackensack, New Jersey, United States
View all 30 locations
View Trial Details

Related conditions